Slide 1Luso del placebo in studi su patologie con dolore Pierangelo Geppetti Farmacologia Clinica, Università di Firenze Centro Cefalee, AOU S. Anna, Ferrara Slide 2 Placebo…

Slide 1TIC TACS or TREATMENT Anti-depressants vs Placebo Joan R. Shepherd, FNP Slide 2 Objectives Estimate the relative benefit of medication vs placebo across a wide range…

Slide 1San Francisco High Risk EM titbits May 2012 Dr Cynthia Lim Slide 2 Penetrating neck trauma by Dr Diane Birnbaumer (Prof UCLA) Penetrates the platysma CRASH –2 trial…

Slide 1Tony Traboulsee, MD (Neurology) University of British Columbia CMSC June 5th, 2004 Toronto, Ontario Defining suboptimal response to MS treatment: MRI outcome Slide…

Slide 1TOK Across the Curriculum Slide 2 Knower(s) Slide 3 Groups 1 and 2 Can translations ever be trusted to carry the original intent? Slide 4 Slide 5 Slide 6 Do people…

Slide 1Mortality Outcome Predictors G. Van den Berghe Frontiers in Neuroendocrinology 23 (2002) : 370-391 Slide 2 Van Den Berghe G, et al. Intensive Insulin Therapy in Critically…

Slide 1Back to the Future: Applying New Evidence in Menopause Management Michael Policar, MD, MPHwww.PolicarLectures.com Slide 2 Topics To Be Discussed New information from…

Slide 1Improving FDAs approach to new drug approval and post-marketing surveillance Jerry Avorn, M.D. Professor of Medicine, Harvard Medical School Chief, Division of Pharmacoepidemiology…

Slide 1Sustainable Medicine New Directions for Research David Servan-Schreiber, MD, Ph.D Clinical Professor of Psychiatry, University of Pittsburgh Lecturer, Faculté de…

Slide 1FIL SPM Course 2010 Voxel-Based Morphometry & DARTEL By John Ashburner & Ged Ridgway Slide 2 Aims of computational neuroanatomy *Many interesting and clinically…